from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Reply of petitioners Amgen Inc., et al. filed. (Distributed)
Brief of respondents Sanofi, et al. in opposition filed.
Brief amici curiae of Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL filed.
Petition for a writ of certiorari filed. (Response due August 27, 2018)
Application (17A1262) granted by The Chief Justice extending the time to file until July 23, 2018.
Application (17A1262) to extend the time to file a petition for a writ of certiorari from May 24, 2018 to July 23, 2018, submitted to The Chief Justice.
Amgen Inc., et al., Petitioner, represented by Jeffrey Alan Lamken
Bristol-Myers Squibb Company, Morphosys AG, Bavarian Nordic A/S, and UCB Biopharma SPRL, Amicus Curiae, represented by Jorge Alberto Goldstein